Therefore, whether acute liver disease and acute kidney injury during the course of SARS-CoV-2 could be developed at the more advanced and severe stadium as well as whether the potential distinction in ALT and creatinine outcomes in both studies could be influenced by the presence of chronic liver diseases before the studies remain unknown. The gene discussed is GPT; the disease is acute kidney injury.